|
GALT Galectin Therapeutics Inc. Common Stock 1133416 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-5,046,000.00 |
| Balance Sheet |
|
Current Assets
|
$15,691,000.00 |
|
Assets
|
$15,759,000.00 |
|
Current Liabilities
|
$7,307,000.00 |
|
Liabilities
|
$145,996,000.00 |
|
Equity
|
$-131,960,000.00 |
|
Shares Out
|
65856898.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,866,000.00 |
| Market Analysis |
Market Cap
|
$212,717,780.54 |
|
Price
|
$3.01 |
|
PB
|
4.15 |
|
EPS
|
-0.08 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:35 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:32 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GALT documents filed with the SEC.
GALT Filings
Clear
